Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FATE-NK100 |
Trade Name | |
Synonyms | FATE NK100 |
Drug Descriptions |
FATE-NK100 are donor-derived natural killer cells, which may induce cell death, and result in increased generation of inflammatory cytokines, thereby mediating an immune response against cancer cells (Cancer Res 2017;77(13 Suppl):Abstract nr 3752). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C137863 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Aldesleukin + FATE-NK100 | Aldesleukin FATE-NK100 | 0 | 1 |
Cetuximab + FATE-NK100 | Cetuximab FATE-NK100 | 0 | 1 |
FATE-NK100 | FATE-NK100 | 0 | 2 |
FATE-NK100 + Trastuzumab | FATE-NK100 Trastuzumab | 0 | 1 |